Related Experiment Videos

Ribose facilitates thallium-201 redistribution in patients with coronary artery disease

N S Perlmutter1, R A Wilson, D A Angello

  • 1Div. of Cardiology, Oregon Health Sciences Univ., Portland 97201-3098.

Insights

Intravenous ribose, an adenine nucleotide precursor, improved thallium-201 redistribution and enhanced identification of ischemic myocardium in coronary artery disease patients. This finding suggests ribose aids in visualizing heart muscle affected by reduced blood flow.

Area of Science:

  • Cardiology
  • Nuclear Medicine
  • Biochemistry

Background:

  • Coronary artery disease (CAD) diagnosis often relies on identifying ischemic myocardium.
  • Thallium-201 (201Tl) redistribution imaging is a key diagnostic tool.
  • Enhancing the sensitivity of 201Tl imaging for ischemia is clinically significant.

Purpose of the Study:

  • To determine if post-ischemic intravenous ribose infusion improves thallium-201 redistribution.
  • To assess if ribose enhances the identification of ischemic myocardium in patients with CAD.

Main Methods:

  • 17 patients with CAD underwent two exercise 201Tl stress tests.
  • Postexercise imaging was followed by either i.v. ribose or saline infusion.
  • Additional imaging occurred at 1 and 4 hours postexercise; defects identified by count-profile analysis.

Main Results:

  • Significantly more reversible 201Tl defects were identified post-ribose compared to post-saline (p < 0.001).
  • This enhancement was observed at both 1 and 4 hours postexercise.
  • Coronary arteriogram analysis confirmed defects were in regions supplied by stenosed arteries.

Conclusions:

  • Intravenous ribose facilitates 201Tl redistribution in patients with CAD.
  • Ribose appears to enhance the identification of ischemic myocardium.
  • Ribose may improve the diagnostic accuracy of stress 201Tl imaging for detecting myocardial ischemia.

Related Concept Videos